Ozempic for weight loss demand forces type 2 diabetics to find alternatives
abc.net.au
science
2022-10-17 05:47:12

A drug shortage has disrupted treatment for diabetics, with normal supply unlikely to return this year, according to a pharmaceutical manufacturer.The Therapeutic Goods Adminstration has advised doctors to limit Ozempic prescriptionsManufacturers say global supply pressures will likely continue into 2023The Pharmacy Guild of Australia says there needs to be greater protection of supply for drugsOzempic is a weekly injectable, which can also be prescribed off-label for weight loss.People wanting to lose weight sent demand sky-high as weight loss successes shared on social media stoked requests at pharmacies and doctors' consulting rooms.
